Concepedia
Statistics
Publications
46
Citations
2K
H-Index
26
Active since
1992
Affiliations
Université de Limoges(Current)
Laboratoire de Biochimie
Centre National de la Recherche Scientifique
Lebanese University
Laboratoire de Chimie
David Y. Léger is an author at Université de Limoges specializing in pharmacology, apoptosis, and life sciences.
Publications per year
1992–2022
Development of curcumin–cyclodextrin/cellulose nanocrystals complexes: New anticancer drug delivery systems
Gautier M.A. Ndong Ntoutoume, Robert Granet, Jean Pierre Mbakidi et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 214 citations
Pharmacy, Pharmaceutics, Pharmacology +12
Diosgenin induces death receptor-5 through activation of p38 pathway and promotes TRAIL-induced apoptosis in colon cancer cells
C. Lepage, David Y. Léger, Julian Bertrand et al. · Cancer Letters · 2010 · 134 citations
Life Sciences, Molecular Biology, Oncology +14
Citral inhibits cell proliferation and induces apoptosis and cell cycle arrest in MCF‐7 cells
Wahid Chaouki, David Y. Léger, Bertrand Liagre et al. · Fundamental and Clinical Pharmacology · 2009 · 127 citations
Life Sciences, Oncology, Pharmacology +16
Photo-Uncaging of a Microtubule-Targeted Rigidin Analogue in Hypoxic Cancer Cells and in a Xenograft Mouse Model
Vincent H. S. van Rixel, Vadde Ramu, Austin B. Auyeung et al. · Journal of the American Chemical Society · 2019 · 121 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +11
Integrin α5β1 Plays a Critical Role in Resistance to Temozolomide by Interfering with the p53 Pathway in High-Grade Glioma
Hana Janoušková, Anne Maglott, David Y. Léger et al. · Cancer Research · 2012 · 119 citations
Medicine, Cancer Biology, Oncology +17
1–5 of 46